YoVDO

The 51st Meeting of the NH/VT Ethics Committees: Navigating Decision-Making Capacity amid Mental Illness Capacity Assessment Part 1 of 4

Offered By: Dartmouth College via Independent

Tags

Continuing Medical Education (CME) Courses Mental Illness Courses

Course Description

Overview

Dartmouth Health Continuing Education for Professionals Home, The 51st Meeting of the NH/VT Ethics Committees: Navigating Decision-Making Capacity amid Mental Illness “ Capacity Assessment “ Part 1 of 4, 10/25/2021 8:00:00 AM - 10/25/2024 8:00:00 AM, Decision-making capacity can be challenging to assess in patients with mental health diagnoses. Clinicians often struggle with the balance between a desire to respect autonomy and a duty to protect. In this conference, we will discuss challenges in decision-making capacity assessment involving adult and pediatric patients with mental health diagnoses.

Presenter
Christine Finn, MD “ Vice Chair for Clinical Services, Department of Psychiatry, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. Dr. Finn is a clinical psychiatrist with experience in the evaluation of patients for clinical decision making capacity. 

Learning Outcome(s)
At the conclusion of this learning activity, (at least 75% of) participants will be able to discuss current issues related to ethical dilemmas posed by patients with mental illness who are asked to make a health care related decision.

Disclosure
The activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported NO financial relationship(s)* with ineligible companies**. 

* A financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).

** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Bibliographic Resources
Schouten R: Psychiatry and the law I: Informed consent, competency, treatment refusal, and civil commitment. Psychiatry Update and Board Preparation, 2/E. Stern TA, Herman JB, editors. 2004; McGraw-Hill, New York; 411-415.

Appelbaum PS, Grisso T: Assessing patients™ capacities to consent to treatment. New England Journal of Medicine, 1988; 319: 1635-1638.

Tags

Related Courses

An Evidence-Based Approach to the Diagnosis and Management of Migraines in Adults in the Primary Care and General Neurology Setting
Stanford University via edX
To Prescribe or Not To Prescribe? Antibiotics and Outpatient Infections
Stanford University via edX
Free of Pain #1 - release back originated pains by yourself
Udemy
The Clinical Picture of Celiac Disease and How to Make the Diagnosis
Columbia University via Independent
How Common is Celiac Disease Around the World? Role of Gluten Timing and Quantity, and Environmental Risk Factors
Columbia University via Independent